Popular Articles
Cellulite Cream

Genetic Factors May Predict Depression In Heart Disease Patients
Individuals with heart disease are twice as likely to suffer from depression as the general population, an association the medical community has largely been unable to explain. Now, a new study by researchers at The Miriam Hospital, in conjunction with The Montrçİal Heart Institute, University of Montrçİal and McGill University, reveals there may be genetic variations that contribute to depression in heart disease patients.
generic viagra online
Applied Infectious Disease Epidemiology Conference, Stockholm, Stockholm, October 26-28, 2009
"Epidemiology is always important and topical, though sometimes unsung," says Professor Johan Giesecke, Chief Scientist at ECDC, the European Centre for Disease Prevention and Control, "but the third applied Infectious Disease Epidemiology Conference in Stockholm in October this year will be an opportunity to put Epidemiology and infectious disease prevention and control into the spotlight; delegates will have the opportunity to discuss and share information on current and emerging infectious diseases, including influenza A (H1N1)v. The call for abstracts closes on July 3rd so there is no time to lose."
News of the day
Lobbyists Battle Over Biologic Drug Protections
"As Congress struggles with a massive health care overhaul, several lobbying powerhouses - including the pharmaceutical industry and the nation"s largest advocacy group for retirees - are locked in a contentious fight over the future of biotechnology drugs," USA Today reports in a front page package. "Both sides have spent heavily to sway lawmakers in the debate over how long to keep the expensive drugs exempt from generic competition." The pharmaceutical industry is fighting for 12 years of exclusivity, while President Barack Obama is "pushing for seven years of exclusivity as he looks to trim costs to help pay for his health care plan. ... The pharmaceutical industry counters that a longer period of exclusivity is needed to recover its investments in "biologic drugs," which are made from living organisms and used to treat cancer, multiple sclerosis and other serious diseases."
Cardiovascular

Lobbyists Continue Pressing Their Cases

Pharmaceutical companies, hospitals, advocacy groups and others with a stake in health reform continue to lobby in hopes of winning concessions in the overhaul, or at least surviving the changes unscathed. "One of the groups key to working any deal is the pharmaceutical industry, which has been quite active behind the scenes," National Public Radio reports. NPR interviewed former congressman Billy Tauzin, who is president of PhRMA, the drug industry"s lobbying group. Tauzin said he couldn"t predict whether health reform, which his group supports, would make the industry wealthier, but added, "we"ll do okay" (7/30). Meanwhile, one Texas hospital has aggressively pursued a lobbying and fundraising campaign to encourage lawmakers to "soften measures that could choke its rapid growth," the New York Times reports. The hospital, Doctors Hospitals at Renaissance, collected nearly $500,000 for the Democratic Senatorial Campaign Committee in March, continuing a years-long campaign to convince members of Congress to shed measures such as one introduced by Rep. Pete Stark, D-Calif., that would limit physician ownership to 40 percent of a given hospital. The hospital in Edinburg, Texas, is doctor owned and was "featured unflatteringly in a June article in [t]he New Yorker about geographic disparities in health care spending" (Sack and Herszenhorn, 7/29). Also, the AFL-CIO, a federation that represents many U.S. trade unions, is seeking to slow momentum in Congress on "a proposal to tax insurance companies that offer the most expensive plans," The Hill reports. The labor lobby successfully opposed a similar tax idea that would levy the penalty on workers or employers with high-cost plans, it remains unclear whether the tax on insurers would amount to the same as the companies pass on the expense to consumers. Many unions won top-notch health benefits in labor negotiations (Young, 7/29). Both labor and "low-income advocates" have complaints about a "free-rider" provision under consideration by a Senate committee, saying it could incent employers to give hiring preference to workers with coverage from a family member, Kaiser Health News reports. The provision would require employers to pay for part of low-income worker"s health insurance subsidies if the company declines to offer insurance, a mandate that is more palatable to businesses than a previous discussed requirement that they provide insurance to all workers. "We are very wary of it," an AFL-CIO spokesman said. "Perhaps unsurprisingly, expenditure on health care and energy lobbying has grown at a faster rate than spending on other topics over the last ten years," Newsweek"s blog, the Gaggle, reports. Between January and June of this year, health care lobbying has totaled more than $250 million, or more than four times the defense industry"s lobbying expenses (Connolly, 7/29). In separate lobbying news, Intermountain Healthcare, a Salt Lake City, Utah-based hospital and health system, delivered "an ultimatum to its lobbying corps: Kick tobacco or else," the Salt Lake Tribune reports. The group told its Washington representatives that it would fire them unless they end existing contracts with tobacco companies or agree not to work for them (Gehrke, 7/29). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):